Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains.
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013.
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.
Fingolimod for the treatment of neurological diseases-state of play and future perspectives.
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
Cognitive Processing Speed is Related to Fall Frequency in Older Adults with Multiple Sclerosis.
Oral corticosteroids for multiple sclerosis relapse.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Role of prolactin in B cell regulation in multiple sclerosis.
Switching Therapies in Multiple Sclerosis.
The Use of Focus Groups to Characterize Symptoms in Persons With Multiple Sclerosis.
Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia.
Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people.
Clinical Nurse Specialist - A serious shortfall in numbers.
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
Pages
« first
‹ previous
…
458
459
460
461
462
463
464
465
466
…
next ›
last »